[
    [
        {
            "time": "",
            "orginal_text": "疫情下布局，不错！自研抗癌药红利期将过，贝达药业拟募资10亿攻新药",
            "features": {
                "keywords": [
                    "疫情",
                    "布局",
                    "自研抗癌药",
                    "红利期",
                    "贝达药业",
                    "募资",
                    "新药"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "疫情下布局，不错！自研抗癌药红利期将过，贝达药业拟募资10亿攻新药",
            "scores": {
                "News_content": "疫情下布局，不错！自研抗癌药红利期将过，贝达药业拟募资10亿攻新药",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "贝达药业：三家股东累计减持2.1%公司股份 减持股份",
            "features": {
                "keywords": [
                    "贝达药业",
                    "股东",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "贝达药业：三家股东累计减持2.1%公司股份 减持股份",
            "scores": {
                "News_content": "贝达药业：三家股东累计减持2.1%公司股份 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "贝达药业(300558.SZ)：3名股东已合计减持844.08万股 减持数量过半 减持股份",
            "features": {
                "keywords": [
                    "贝达药业",
                    "股东",
                    "减持",
                    "数量过半"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "贝达药业(300558.SZ)：3名股东已合计减持844.08万股 减持数量过半 减持股份",
            "scores": {
                "News_content": "贝达药业(300558.SZ)：3名股东已合计减持844.08万股 减持数量过半 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "贝达药业上市后研发增近三倍 募资10亿加快新药上市",
            "features": {
                "keywords": [
                    "贝达药业",
                    "上市",
                    "研发",
                    "募资",
                    "新药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "贝达药业上市后研发增近三倍 募资10亿加快新药上市",
            "scores": {
                "News_content": "贝达药业上市后研发增近三倍 募资10亿加快新药上市",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]